This is the archive of Swiss Biotech Day, up to the 2026 edition. For the current edition, visit swissbiotechday.ch.
Company name
Topadur Pharma AG
Company profile

With increasing life expectancy, aging-related diseases are rising, yet effective treatments remain limited. Topadur Pharma AG is a Swiss clinical-stage biotech company based in Schlieren, Zurich. Its DualTOP™ platform targets the cGMP system to restore microcirculation, promote blood vessel regeneration, and enhance tissue repair. Using this technology, Topadur develops first-in-class therapies for chronic wounds, alopecia, skin aging, and cancer.

Date, time and room information

Monday, May 4, 14:45 - 15:00, room Montreal

Category
Clinical stage development company
Speaker information
Name Position Institution
Matthias Schaefer CEO Topadur Pharma AG